Antimicrobial stewardship program achieved marked decrease in Clostridium difficile infections in a Veterans Hospital - 26/08/20
Highlights |
• | Clostridium difficile infection (CDI) is a common side effect of antimicrobial therapy. |
• | Antimicrobial stewardship programs (ASP) had demonstrated success in decreasing hospital acquired CDI. |
• | ASP limiting fluroquinolone and piperacillin-tazobactam use can lead to decreased hospital acquired CDI. |
Résumé |
Clostridium (or Clostridioides) difficile infection (CDI) is a common side effect of antimicrobial therapy and is increasingly linked with health care-associated transmissions. Antimicrobial stewardship programs (ASP) have demonstrated success in decreasing in-hospital CDI cases. We implemented an ASP targeting inappropriate or unnecessary use of all antibiotics especially empiric piperacillin-tazobactam and fluoroquinolone use. Concurrently, we monitored all health-care associated CDI. Our CDI cases were markedly decreased after initiation of our ASP.
Le texte complet de cet article est disponible en PDF.Key Words : Clostridioides difficile infection, Antimicrobial stewardship, Infection control
Plan
Vol 48 - N° 9
P. 1119-1121 - septembre 2020 Retour au numéro
Article précédent
- The effect of pulsed xenon ultraviolet light disinfection on healthcare-associated Clostridioides difficile rates in a tertiary care hospital
- Fibi Attia, Cynthia Whitener, Scott Mincemoyer, Justin Houck, Kathleen Julian
- Safety briefing and visual design key to protecting health care personnel during the COVID-19 pandemic
- Lisa Kuhn, Zheng Jie Lim, Daphne Flynn, Eden Potter, Diana Egerton-Warburton, COVID19AsOne Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?